NCT04690504View on ClinicalTrials.gov

Validation of Circadian Biomarkers in Patients With Sleep Disorders

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

June 30, 2024

Study Completion Date

July 1, 2024

Conditions
Sleep Disorders, Circadian RhythmCircadian Rhythm DisordersCircadian Rhythm Sleep DisorderAdvanced Sleep Phase Syndrome (ASPS)Delayed Sleep Phase SyndromeSleep Wake DisordersSleep Disorder
Interventions
OTHER

dim light melatonin onset (DLMO)

A series of saliva samples will be collected and assayed for melatonin so that the timing of melatonin secretion onset can be determined.

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT04690504 - Validation of Circadian Biomarkers in Patients With Sleep Disorders | Biotech Hunter | Biotech Hunter